Entrada Therapeutics, Inc.
Total Trades
107
Buys
9
Sells
75
Largest Trade
N/A
Insiders
10
Institutional Funds
75
Inst. Value
$1M+
Activist Filings
19
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| WENTWORTH KORY JAMES | CFO | SELL | $50K–$100K | 8K | $12.25 | Mar 6, 2026 |
| WENTWORTH KORY JAMES | CFO | SELL | $50K–$100K | 9K | $9.98 | Nov 24, 2025 |
| BAKER BROS. ADVISORS LP | 10% Owner | BUY | $100K–$500K | 29K | $9.07 | Nov 24, 2025 |
| PARMAR KUSH | Director | SELL | $1M+ | 200K | $8.80 | Nov 18, 2025 |
| 5AM Ventures V, L.P. | 10% Owner | SELL | $1M+ | 200K | $8.80 | Nov 18, 2025 |
| BAKER BROS. ADVISORS LP | 10% Owner | BUY | $1M+ | 178K | $7.60 | Nov 12, 2025 |
| PARMAR KUSH | Director | SELL | $100K–$500K | 27K | $7.50 | Jul 11, 2025 |
| 5AM Ventures V, L.P. | 10% Owner | SELL | $100K–$500K | 27K | $7.50 | Jul 11, 2025 |
| PARMAR KUSH | Director | SELL | $500K+ | 125K | $6.93 | Jul 2, 2025 |
| 5AM Ventures V, L.P. | 10% Owner | SELL | $500K+ | 125K | $6.93 | Jul 2, 2025 |
| WENTWORTH KORY JAMES | CFO | SELL | $15K–$50K | 2K | $10.67 | Mar 19, 2025 |
| WENTWORTH KORY JAMES | CFO | EXERCISE | $1K–$15K | 6K | $2.10 | Dec 3, 2024 |
| WENTWORTH KORY JAMES | CFO | SELL | $100K–$500K | 6K | $19.99 | Dec 3, 2024 |
| Sethuraman Natarajan | President | SELL | $100K–$500K | 16K | $20.18 | Dec 3, 2024 |
| Sethuraman Natarajan | President | SELL | $50K–$100K | 4K | $20.03 | Nov 13, 2024 |
| WENTWORTH KORY JAMES | CFO | EXERCISE | $1K–$15K | 6K | $2.10 | Nov 13, 2024 |
| WENTWORTH KORY JAMES | CFO | SELL | $100K–$500K | 9K | $19.98 | Nov 13, 2024 |
| Sethuraman Natarajan | President | SELL | $100K–$500K | 18K | $18.62 | Nov 6, 2024 |
| Sethuraman Natarajan | President | SELL | $1K–$15K | 600 | $18.00 | Oct 18, 2024 |
| Dowden Nathan J | President & COO | SELL | $1K–$15K | 847 | $16.00 | Sep 30, 2024 |
| Dowden Nathan J | President & COO | EXERCISE | $15K–$50K | 20K | $1.74 | Aug 20, 2024 |
| Dowden Nathan J | President & COO | SELL | $100K–$500K | 27K | $16.27 | Aug 20, 2024 |
| Doshi Dipal | CEO | SELL | $15K–$50K | 1K | $16.17 | Jun 14, 2024 |
| KIM PETER S | Director | BUY | $15K–$50K | 3K | $13.57 | Apr 10, 2024 |
| KIM PETER S | Director | BUY | $15K–$50K | 2K | $13.75 | Apr 1, 2024 |
| KIM PETER S | Director | BUY | $100K–$500K | 9K | $13.58 | Mar 26, 2024 |
| KIM PETER S | Director | BUY | $15K–$50K | 3K | $12.81 | Mar 21, 2024 |
| Doshi Dipal | CEO | SELL | $15K–$50K | 1K | $15.00 | Feb 20, 2024 |
| Doshi Dipal | CEO | SELL | $15K–$50K | 1K | $15.99 | Jan 18, 2024 |
| WENTWORTH KORY JAMES | CFO | SELL | $100K–$500K | 13K | $15.59 | Dec 26, 2023 |
| WENTWORTH KORY JAMES | CFO | EXERCISE | $15K–$50K | 13K | $2.10 | Dec 26, 2023 |
| Doshi Dipal | President and CEO | SELL | $15K–$50K | 1K | $15.00 | Dec 22, 2023 |
| Doshi Dipal | President and CEO | SELL | $15K–$50K | 1K | $16.23 | Nov 13, 2023 |
| Doshi Dipal | President and CEO | SELL | $15K–$50K | 1K | $15.00 | Oct 19, 2023 |
| Doshi Dipal | President and CEO | SELL | $15K–$50K | 1K | $15.00 | Sep 15, 2023 |
| WENTWORTH KORY JAMES | CFO | GRANT | N/A | 14K | — | Sep 6, 2023 |
| WENTWORTH KORY JAMES | CFO | SELL | $1K–$15K | 950 | $13.48 | Sep 6, 2023 |
| KREHER NERISSA | Chief Medical Offi… | GRANT | N/A | 14K | — | Sep 6, 2023 |
| KREHER NERISSA | Chief Medical Offi… | SELL | $1K–$15K | 892 | $13.48 | Sep 6, 2023 |
| Dowden Nathan J | COO | GRANT | N/A | 14K | — | Sep 6, 2023 |
| Dowden Nathan J | COO | SELL | $1K–$15K | 972 | $13.47 | Sep 6, 2023 |
| Doshi Dipal | President and CEO | SELL | $15K–$50K | 1K | $15.67 | Aug 16, 2023 |
| KREHER NERISSA | Chief Medical Offi… | EXERCISE | $50K–$100K | 27K | $2.10 | Aug 4, 2023 |
| KREHER NERISSA | Chief Medical Offi… | SELL | $100K–$500K | 27K | $14.76 | Aug 4, 2023 |
| WENTWORTH KORY JAMES | CFO | SELL | $100K–$500K | 10K | $17.99 | Jul 12, 2023 |
| WENTWORTH KORY JAMES | CFO | EXERCISE | $15K–$50K | 10K | $2.10 | Jul 12, 2023 |
| Dowden Nathan J | COO | SELL | $100K–$500K | 7K | $18.03 | Jul 12, 2023 |
| Sethuraman Natarajan | Chief Scientific O… | SELL | $100K–$500K | 18K | $18.03 | Jul 12, 2023 |
| WENTWORTH KORY JAMES | CFO | EXERCISE | $15K–$50K | 18K | $2.10 | Jun 23, 2023 |
| WENTWORTH KORY JAMES | CFO | SELL | $100K–$500K | 18K | $15.01 | Jun 23, 2023 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 75 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| 5AM Venture Management, LLC | 4.1M | $1M+ | SH |
| VANGUARD GROUP INC | 1.5M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 556K | $1M+ | SH |
| STATE STREET CORP | 509K | $1M+ | SH |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 363K | $1M+ | SH |
| ACADIAN ASSET MANAGEMENT LLC | 311K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 253K | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 252K | $1M+ | SH |
| ROYCE & ASSOCIATES LP | 247K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 221K | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 181K | $1M+ | SH |
| SPHERA FUNDS MANAGEMENT LTD. | 111K | $1M+ | SH |
| MOORE CAPITAL MANAGEMENT, LP | 105K | $1M+ | SH |
| GOLDMAN SACHS GROUP INC | 89K | $500K+ | SH |
| AMERICAN CENTURY COMPANIES INC | 75K | $500K+ | SH |
| BlackRock, Inc. | 70K | $500K+ | SH |
| BARCLAYS PLC | 67K | $500K+ | SH |
| CANTOR FITZGERALD, L. P. | 57K | $500K+ | SH |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 57K | $500K+ | SH |
| Nan Fung Group Holdings Ltd | 49K | $500K+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Nov 25, 2025
5.0%
1.9M shares
SC 13D/A · Nov 18, 2025
7.8%
3.0M shares
T. Rowe Price Associates, Inc.
SC 13G/A · Nov 14, 2025
0.9%
361K shares
T. Rowe Price Associates, Inc.
SC 13G/A · Aug 14, 2025
6.8%
2.6M shares
SC 13G/A · Aug 14, 2025
4.0%
1.5M shares
SC 13G/A · May 14, 2025
5.6%
2.1M shares
SC 13G/A · Feb 14, 2025
6.9%
2.6M shares
SC 13G · Feb 14, 2025
5.6%
2.1M shares
SC 13G · Feb 4, 2025
5.3%
2.0M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Nov 14, 2024
8.2%
3.0M shares
SC 13D/A · Jun 26, 2024
13.2%
4.9M shares
SC 13G/A · Feb 14, 2024
3.8%
1.3M shares
SC 13G/A · Feb 14, 2024
8.2%
2.7M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2024
9.0%
3.0M shares
SC 13G/A · Feb 14, 2023
5.9%
1.9M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2023
9.6%
3.0M shares
SC 13G · Feb 14, 2022
6.3%
2.0M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G · Feb 14, 2022
6.4%
2.0M shares
SC 13G · Feb 14, 2022
9.0%
2.8M shares